Hemispherx Biopharma Inc (HEB)

0.37
0.00 0.05
AMEX : Health Care
Prev Close 0.37
Open 0.35
Day Low/High 0.35 / 0.38
52 Wk Low/High 0.06 / 0.21
Volume 175.39K
Avg Volume 298.50K
Exchange AMEX
Shares Outstanding 29.17M
Market Cap 11.96M
EPS -0.30
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Hemispherx Biopharma To Host Conference Call To Discuss Second Quarter Financial Results On Tuesday, August 15, 2017

Hemispherx Biopharma To Host Conference Call To Discuss Second Quarter Financial Results On Tuesday, August 15, 2017

Financials for Second Quarter Ended June 30, 2017 will be released on August 14, 2017

Hemispherx Encouraged By Cytokine Biomarker Discovery Which May Lead To A Diagnostic For Chronic Fatigue Syndrome

Hemispherx Encouraged By Cytokine Biomarker Discovery Which May Lead To A Diagnostic For Chronic Fatigue Syndrome

Cytokine Signatures Could Lead to the First Empirical Measure of Disease Severity in Chronic Fatigue Syndrome

Hemispherx Updates Status Of Immuno-Oncology Program In Pancreatic Cancer

Hemispherx Updates Status Of Immuno-Oncology Program In Pancreatic Cancer

12 Pancreatic Cancer Patients Receiving Ampligen® Immuno-Oncology Therapy in Early Access Program

Hemispherx Biopharma Repurposes Ampligen In Immuno-Oncology

Joseph C. Horvath, M.D., Named Deputy Chief Medical Officer to Oversee Ampligen European Pancreatic Cancer Programs

Hemispherx Biopharma Enhances Ampligen Manufacturing And Scientific Capabilities

Promotes Carol Smith, Ph.D., to Chief Manufacturing Officer and Deputy Chief Scientific Officer

Hemispherx Biopharma Announces Financial Results For The Three Months Ended March 31, 2017

The company has generated revenues from the lots of newly manufactured Ampligen

What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016

What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016

TheStreet's biotech columnist offers his own report card on biotech stocks.

Hemispherx Biopharma Announces Financial Results In Its Quarterly Report For The Nine Months Ended September 30, 2016

Hemispherx Biopharma Announces Financial Results In Its Quarterly Report For The Nine Months Ended September 30, 2016

Conference Call Scheduled for Tuesday, November 15, 2016 at 11:00 AM EST

Hemispherx Biopharma To Present At The 18th Annual Rodman & Renshaw Global Investment Conference

Hemispherx Biopharma To Present At The 18th Annual Rodman & Renshaw Global Investment Conference

Recent Articles on Hemispherx Biopharma by BioWorld and Pink Sheet Posted to Corporate Website